Compounds > catechin

catechin and Hepatitis C

catechin has been researched along with Hepatitis C in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19904 (22.22)18.7374
1990's1 (5.56)18.2507
2000's0 (0.00)29.6817
2010's11 (61.11)24.3611
2020's2 (11.11)2.80

Authors

AuthorsStudies
Li, Y; Lin, W; Liu, D; Proksch, P; Yu, S1
Darwish, NHE; Elbasiony, M; Mousa, SA; Shiha, G; Soliman, R1
Akber Ansari, S; Ali, R; Badshah, SL; Bari, A; Jamal, SB; Majid Mahmood, H; Shahid, F; Sohaib, M; Ullah, R1
Ho, WZ; Li, JL; Wang, X; Wang, YZ; Zhang, T1
Abdelaziz, AI; El Sobky, SA; El-Ekiaby, N; El-Sayed, M; Elemam, NM; Esmat, G; Hamza, MT; Mekky, RY; Youness, RA1
Abdelaziz, AI; El-Ekiaby, NM; El-Sayed, M; Elemam, NM; Esmat, G; Hamza, MT; Mekky, RY1
Burton, DR; Douglas, D; Egli, A; Forester, S; Houghton, M; Humar, A; Kneteman, N; Lambert, J; Law, J; Law, M; Lund, G; O'Shea, D; Tyrrell, DL1
Khan, H; Murad, S; Neyts, J; Paeshuyse, J1
Hattori, T; Inoue, Y; Kodama, EN; Li, S; Matsuura, Y; Tanaka, T; Tani, H; Zhang, J1
Ciesek, S; Colpitts, CC; Friesland, M; Manns, MP; Meuleman, P; Ott, M; Pietschmann, T; Schang, LM; Steinmann, E; Steinmann, J; von Hahn, T; Wedemeyer, H1
Albecka, A; Belouzard, S; Calland, N; Descamps, V; Dubuisson, J; Duverlie, G; Hober, D; Rouillé, Y; Séron, K; Wychowski, C1
Jo, SK; Kim, SE; Roh, C1
Fukazawa, H; Murakami, Y; Suzuki, T; Wakita, T1
Göbel, J; Pausch, V1
Babiuch, L; Poznańska, H; Rychalska, B1
Patrick, L1
Boroń, P; Boroń-Kaczmarska, A; Nadowska, K; Sokolewicz-Bobrowska, E; Szpakowicz, T1
Judmaier, G1

Reviews

2 review(s) available for catechin and Hepatitis C

ArticleYear
Hepatitis C: epidemiology and review of complementary/alternative medicine treatments.
    Alternative medicine review : a journal of clinical therapeutic, 1999, Volume: 4, Issue:4

    Topics: Antioxidants; Antiviral Agents; Catechin; Complementary Therapies; Disease Progression; Glycyrrhizic Acid; Hepacivirus; Hepatitis C; Humans; Phytosterols; Plant Extracts; Ribavirin; Silymarin

1999
[Epidemiology, clinical aspects and prognosis of viral hepatitis A, B and non-A, non-B].
    Acta medica Austriaca. Supplement, 1988, Volume: 37

    Topics: Catechin; Cross-Sectional Studies; Hepatitis A; Hepatitis Antibodies; Hepatitis B; Hepatitis C; Hepatitis Viruses; Hepatitis, Viral, Human; Humans; Prognosis; Risk Factors

1988

Trials

3 trial(s) available for catechin and Hepatitis C

ArticleYear
Novel combined single dose anti-hepatitis C therapy: a pilot study.
    Scientific reports, 2021, 02-25, Volume: 11, Issue:1

    Topics: Adult; Antiviral Agents; Catechin; Female; Genotype; Hepatitis C; Humans; Male; Middle Aged; Pilot Projects; Ribavirin; Sofosbuvir

2021
[Effect of catergen on the course of acute viral hepatitis].
    Przeglad epidemiologiczny, 1981, Volume: 35, Issue:4

    Topics: Acute Disease; Antiviral Agents; Benzopyrans; Catechin; Clinical Trials as Topic; Hepatitis B; Hepatitis C; Hepatitis, Viral, Human; Humans; Random Allocation

1981
[Evaluation of therapeutic effect of catergen in viral hepatitis].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1979, Aug-13, Volume: 34, Issue:33

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Benzopyrans; Catechin; Clinical Trials as Topic; Female; Hepatitis B; Hepatitis C; Hepatitis, Viral, Human; Humans; Male; Middle Aged

1979

Other Studies

13 other study(ies) available for catechin and Hepatitis C

ArticleYear
Inhibitory effects of polyphenols toward HCV from the mangrove plant Excoecaria agallocha L.
    Bioorganic & medicinal chemistry letters, 2012, Jan-15, Volume: 22, Issue:2

    Topics: Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Enzyme Inhibitors; Euphorbiaceae; Hepatitis C; Humans; Molecular Conformation; Polyphenols; RNA, Viral; Structure-Activity Relationship; Viral Nonstructural Proteins

2012
Identification of Potential HCV Inhibitors Based on the Interaction of Epigallocatechin-3-Gallate with Viral Envelope Proteins.
    Molecules (Basel, Switzerland), 2021, Feb-26, Volume: 26, Issue:5

    Topics: Antiviral Agents; Catechin; Hepacivirus; Hepatitis C; Humans; Ligands; Molecular Docking Simulation; Polyphenols; Tea; Viral Envelope; Viral Envelope Proteins; Virus Internalization

2021
(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
    World journal of gastroenterology, 2017, Aug-28, Volume: 23, Issue:32

    Topics: Antiviral Agents; Catechin; Cell Line, Tumor; DEAD Box Protein 58; Enzyme-Linked Immunosorbent Assay; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Immunity, Innate; Interferon-gamma; Interferon-Stimulated Gene Factor 3, gamma Subunit; Poly I-C; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Signal Transduction; Toll-Like Receptor 3; Viral Core Proteins; Virus Replication

2017
Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models.
    Archives of virology, 2019, Volume: 164, Issue:6

    Topics: 3' Untranslated Regions; Case-Control Studies; Catechin; Cell Line; Computer Simulation; Gene Expression Profiling; Gene Expression Regulation; Hepacivirus; Hepatitis C; Humans; MicroRNAs; Tetraspanin 28; Virus Internalization

2019
Mir-194 is a hepatocyte gate keeper hindering HCV entry through targeting CD81 receptor.
    The Journal of infection, 2015, Volume: 70, Issue:1

    Topics: Catechin; Computational Biology; Flow Cytometry; Hepacivirus; Hepatitis C; Humans; Liver; Liver Transplantation; MicroRNAs; Reverse Transcriptase Polymerase Chain Reaction; Tetraspanin 28; Up-Regulation

2015
Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2016, Volume: 22, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antiviral Agents; Broadly Neutralizing Antibodies; Catechin; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Genotype; Hepatitis C; Hepatitis Viruses; Humans; Liver; Mice, SCID; Time Factors

2016
Assessment of the activity of directly acting antivirals and other products against different genotypes of hepatitis C virus prevalent in resource-poor countries.
    Antiviral research, 2016, Volume: 125

    Topics: Antiviral Agents; Catechin; Food Additives; Genotype; Hepacivirus; Hepatitis C; Humans; Nitro Compounds; Prevalence; Silybin; Silymarin; Thiazoles; Virus Replication

2016
Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication.
    Antiviral chemistry & chemotherapy, 2010, Aug-11, Volume: 20, Issue:6

    Topics: Antiviral Agents; Biflavonoids; Catechin; Cell Line, Tumor; Cinnamomum zeylanicum; Drugs, Chinese Herbal; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Proanthocyanidins; Recombinant Proteins; Replicon; Ribavirin; RNA, Viral; Virus Internalization; Virus Replication

2010
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.
    Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:6

    Topics: Catechin; Cell Line, Tumor; Cells, Cultured; Hepacivirus; Hepatitis C; Humans; Tea; Virus Attachment; Virus Internalization

2011
(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Hepatology (Baltimore, Md.), 2012, Volume: 55, Issue:3

    Topics: Animals; Antiviral Agents; Catechin; Cattle; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Kidney; Lipid Metabolism; Models, Animal; Plant Extracts; Tea; Vero Cells; Virus Internalization; Virus Replication

2012
Label free inhibitor screening of hepatitis C virus (HCV) NS5B viral protein using RNA oligonucleotide.
    Sensors (Basel, Switzerland), 2011, Volume: 11, Issue:7

    Topics: Antiviral Agents; Aptamers, Nucleotide; Biotin; Catechin; Computer Systems; Hepacivirus; Hepatitis C; Humans; Streptavidin; Viral Nonstructural Proteins

2011
A cell-based, microplate colorimetric screen identifies 7,8-benzoflavone and green tea gallate catechins as inhibitors of the hepatitis C virus.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:8

    Topics: Antiviral Agents; Benzoflavones; Camellia sinensis; Catechin; Cell Line, Tumor; Cyclosporine; Drug Evaluation, Preclinical; Flavones; Hepacivirus; Hepatitis C; Humans; Phytotherapy; Reproducibility of Results; Tamoxifen

2012
[Immunohematologic studies on the correlations between (+)-cyanidanol-3-(catergen) therapy and hemolytic anemia].
    Wiener medizinische Wochenschrift (1946), 1983, Nov-15, Volume: 133, Issue:21

    Topics: Anemia, Hemolytic, Autoimmune; Benzopyrans; Catechin; Erythrocytes; Hemagglutination Tests; Hepatitis C; Humans; Liver Cirrhosis; Penicillin G

1983